OFFICIAL SOURCE FACTS / REQUIREMENT FRAMEWORK
What you need to know
- EDA publishes a March 2026 guideline governing imported pharmaceutical and biological-product shelf life, including exception processes and category-specific conditions.
- Review the original document for the conditions applicable to the shipment. This brief does not reproduce numeric thresholds.
This summary is not a complete regulatory checklist. Applicability, conditions and exclusions remain governed by the original official document.
Who is affected
- Foreign manufacturers
- Exporters
- Importers
- Regulatory Affairs
- Supply Chain teams
PHARMA GATE INTERPRETATION — NOT AN OFFICIAL REQUIREMENT
Pharma Gate Intelligence
Check applicable shelf-life conditions before finalizing shipment and market-entry execution. Exceptions should not be assumed.
Business impact
Shelf-life compliance can affect import readiness, shipment and inventory planning.
RECOMMENDED ACTION — NOT A REGULATORY DETERMINATION
What to check
- Product category and shipment circumstances
- Applicable shelf-life provisions and any exception route
- Arrival planning and supporting batch information
Recommended next step
Review the official guideline with regulatory and supply-chain teams before confirming shipment.
- Product category
- Shelf-life applicability
- Shipment planning
- Documentation review
- Regulatory support
NEXT STEP
Need help navigating this requirement?
Pharma Gate is not a regulatory authority. Professional providers are independent organizations subject to platform review.